surmount-1 tirzepatide weight loss nondiabetic Body composition changes during reduction with in the SURMOUNT‐1 study of adults with obesity or overweight - Look - 2025 - Diabetes, Obesity and Metabolism Gastrointestinal tolerability and weight reduction

Treatment adjustments should always be made under the supervision of a healthcare professional

The study found that a 6month use of semaglutide 2.4 mg resulted in a 10% decrease in weight and a reduction of 10.5 kg in adult participants with overweight/obesity

inflammation of your pancreas (pancreatitis)

Your initial evaluation is typically in person at our Fort Worth clinic (Alliance area, 4801 Golden Triangle Blvd), with ongoing monitoring, dose adjustments, and check-ins available via telehealth for your convenience

While taking Trulicity, you should regularly check your bodyweight, heart rate, and blood glucose levels

Sessions are recommended 4 weeks apart